The present study investigates the influence of the addition of l-arginine to a matrix of carboxymethylated nanofibrillated cellulose (CMC-NFC), with the aim of fabricating a mobile carrier facilitated transport membrane for the separation of CO. Self-standing films were prepared by casting an aqueous suspension containing different amounts of amino acid (15-30-45 wt.%) and CMC-NFC. The permeation properties were assessed in humid conditions (70-98% relative humidity (RH)) at 35 °C for CO and N separately and compared with that of the non-loaded nanocellulose films. Both permeability and ideal selectivity appeared to be improved by the addition of l-arginine, especially when high amino-acid loadings were considered. A seven-fold increment in carbon dioxide permeability was observed between pure CMC-NFC and the 45 wt.% blend (from 29 to 220 Barrer at 94% RH), also paired to a significant increase of ideal selectivity (from 56 to 185). Interestingly, while improving the separation performance, water sorption was not substantially affected by the addition of amino acid, thus confirming that the increased permeability was not related simply to membrane swelling. Overall, the addition of aminated mobile carriers appeared to provide enhanced performances, advancing the state of the art for nanocellulose-based gas separation membranes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630413 | PMC |
http://dx.doi.org/10.3390/nano9060877 | DOI Listing |
Pharmaceutics
November 2024
School of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430023, China.
: Sodium aescinate (SA) is commonly used topically due to its anti-inflammatory, anti-edematous, and anti-swelling properties. However, the clinical application of SA is limited by strong irritation, and cannot be used on the damaged skin and mucous membrane. This study aimed to investigate whether arginine hydrochloride (Arg·HCl) could reduce the rectal mucosal irritation of SA through the formation of a gel.
View Article and Find Full Text PDFMicroorganisms
December 2024
Institute for Research Initiatives, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma 630-0192, Nara, Japan.
Proline is the most abundant amino acid in wine and beer, largely due to the limited utilization of proline by the yeast during fermentation. Previous studies have shown that the arginine transporter Can1 plays a role in regulating proline utilization by acting as a transceptor, combining the functions of both a transporter and a receptor for basic amino acids. However, the -disrupted strains have exhibited the inhibition of proline utilization under nutrient-rich conditions, indicating that additional factors beyond basic amino acids contribute to the inhibition of proline utilization.
View Article and Find Full Text PDFMolecules
December 2024
Department of Immunobiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19 St., 20-033 Lublin, Poland.
Antimicrobial peptides (AMPs) constitute a large and diverse group of molecules with antibacterial, antifungal, antiviral, antiprotozoan, and anticancer activity. In animals, they are key components of innate immunity involved in fighting against various pathogens. Proline-rich (Pr) AMPs are characterized by a high content of proline (and arginine) residues that can be organized into Pro-Arg-Pro motifs.
View Article and Find Full Text PDFCancers (Basel)
December 2024
College of Medicine, QU Health, Qatar University, Doha 2713, Qatar.
Small cell lung cancer (SCLC) is an extremely aggressive form of lung cancer, characterized by rapid progression and poor survival rates. Despite the importance of early diagnosis, the current diagnostic techniques are invasive and restricted. This study presents a novel stacking-based ensemble machine learning approach for classifying small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) using metabolomics data.
View Article and Find Full Text PDFHomozygous MTAP deletion occurs in ~15% of cancers, making them vulnerable to decreases in the concentration of S-adenosylmethionine (SAM). AG-270/S095033 is an oral, potent, reversible inhibitor of methionine adenosyltransferase 2 A (MAT2A), the enzyme primarily responsible for the synthesis of SAM. We report results from the first-in-human, phase 1 trial of AG-270/S095033 as monotherapy in patients with advanced malignancies (ClinicalTrials.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!